Treeline Biosciences
1 known investors
Treeline Biosciences designs drug development candidates targeting oncology, immunology, and neurology through a combination of inhibitors, protein degraders, and antibody drug conjugates, leveraging in silico modeling and machine learning to optimize drug discovery.
AI & Machine LearningBiotech